Analysis of Patients with Transplant-Eligible NDMM with High-Risk Cytogenetic Abnormalities who Received Frontline Daratumumab-Based Quadruplet Therapy

Video

Sandy Wong, MD, presents data from a subgroup analysis of the GRIFFIN and MASTER trials in patients with transplant-eligible NDMM.

Related Videos
Experts on multiple myeloma
Experts on multiple myeloma
Experts on multiple myeloma
Experts on multiple myeloma
Experts on multiple myeloma
Experts on MM
Related Content